<DOC>
	<DOC>NCT00563732</DOC>
	<brief_summary>Primary: To evaluate the effects of multiple doses of lecozotan SR on the PK profile of a single dose of digoxin in healthy adult subjects. Secondary: To assess the safety and tolerability of the coadministration of lecozotan SR and digoxin.</brief_summary>
	<brief_title>Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Women of non childbearing potential and men aged 18 to 55 years at screening. Body mass index (BMI) in the range of 18 to 30 kg/m2 and body weight 50 kg (BMI = weight (kg)/[height (m)] Presence or history of any disorder that may prevent the successful completion of the study. Any clinically important deviation from normal limits in physical examination, vital signs or clinical laboratory test results.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>